Sustained release aminopyridine composition

  • US 8,663,685 B2
  • Filed: 07/20/2011
  • Issued: 03/04/2014
  • Est. Priority Date: 12/11/2003
  • Status: Active Grant
First Claim
Patent Images

1. A method of improving walking in a human multiple sclerosis patient in need thereof comprising orally administering to said patient a sustained release composition of 10 milligrams of 4-aminopyridine twice daily for a time period of at least two weeks, wherein the sustained release composition further comprises one or more pharmaceutically acceptable excipients.

View all claims
  • 1 Assignment
Timeline View
Assignment View